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ELECTROSPUN POLYCAPROLACTONE NANOFIBERS 
ABSTRACT 
 
 
 
Controlled release of hydrophilic biological agents is difficult to be achieved with 
conventional approaches such as single electrospinning. One recent approach for 
controlled release is production of core-shell fibers via modified coaxial 
electrospinning. In this study, the application area of this technique was expanded by 
using it for a hydrophilic drug (ampicillin) which is known to have low compatibility 
with polycaprolactone (PCL). A partially electrospinnable 4% (w/v) PCL solution 
was used as a shell fluid in order to create ampicillin-loaded PCL nanofibers shelled 
by a PCL shield. Scanning electron microscopy and optical microscopy verified that 
the membranes consisted of nanofibers with core-shell structure. Furthermore, 
Fourier transform infrared spectroscopy demonstrated that some compatibility might 
be present between ampicillin and PCL. Finally, drug release studies showed that the 
drug release kinetics of core-shell products is closer to zero-order kinetics as 
compared to the products of single electrospinning. Together, these imply that the 
application area of modified electrospinning in controlled release could be expanded 
to polymers and drugs with low compatibility. 
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ZAHIDA SULTANOVA 
 
ORTAK EKSENLİ ELEKTROEĞİLMİŞ POLİKAPROLAKTON 
NANOFİBERLERDEN AMPİSİLİNİN KONTROLLÜ SALIMI 
ÖZET 
 
 
 
Hidrofilik biyolojik ajanların kontrollü salımını gerçekleştirecek ortamların 
oluşturulmasında tekli elektro-eğirme gibi geleneksel yöntemler yetersiz 
kalmaktadır. Kontrollü salım için öne sürülen yaklaşımlardan biri modifiye ortak 
eksenli elektroeğirme yöntemi ile kabuk-çekirdek biçiminde fiberler üretimidir. Bu 
çalışmada, hidrofilik ve model polimerle uyumluluğu az olan bir ilaç kullanılarak, 
bahsedilen yöntemin kullanım alanı genişletilmiştir. Polikaprolakton (PCL) ile 
kaplanmış ampisilin içeren PCL nanofiberlerinin üretimi için kısmen 
elektroeğrilebilen %4 (ağırlık/hacim) polikaprolakton çözeltisi kabuk sıvısı olarak 
kullanılmıştır. Taramalı elektron mikroskopu ve optik mikroskop sonuçları ile 
membranların kabuk-çekirdek biçiminde nanofiberlerden oluştuğu kanıtlanmıştır. 
Fourier dönüşümlü kızılötesi spektroskopisi ile ampisilin ile PCL arasında az 
miktarda uyumluluk olabileceği gözlenmiştir. Son olarak ilaç salım çalışmalarında 
kabuk-çekirdek biçimindeki membranlardan ilaç salımının tekli elektroeğrilmiş 
membranlara göre sıfırıncı dereceden kinetik denklemine daha uygun olduğu 
saptanmıştır. Bu sonuçlar ışığında modifiye otak eksenli elektroeğirme yönteminin 
ilaç salımındaki kullanım alanının uyumluluğu az olan polimer ve ilaçlar için 
genişletilebileceği görülmüştür. 
 
 
 
 
 
Anahtar Kelimeler: Kontrollü salım, Çift eksenli elektroeğirme, İlaç salım 
membranı, Polikaprolakton, Ampisilin
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1. INTRODUCTION 
1.1. Introduction and Aim 
 
Electrospinning is a technique in which high voltage is used in order to overcome the 
surface tension of polymer solutions which results with nano/micro-scaled fibers [1]. 
The nanofibers produced by this process have controllable membrane thickness, 
large surface area to volume ratio, and can be used as membranes after they are 
randomly assembled [2]. These membranes have applications in several fields 
including filtration, tissue engineering, pharmaceutics and drug delivery [3-8]. In 
drug delivery applications, various controlled drug release profiles (delayed, 
immediate, sustained etc.) can be achieved by using electrospun nanofibrous 
membranes as carriers [9, 10]. Sustained drug release has attracted significant 
attention among them because it can lead to desired duration and dosage of drugs in 
target tissues [11]. 
 
In order to prepare a drug-loaded nanofibrous membrane, the model drug should be 
dissolved together with the polymer and then electrospun under appropriate 
processing conditions. In such membranes, the initial burst release is unavoidable 
due to the drug distribution on the surface of the nanofibers, large nanofiber surface 
areas, and amorphous status of the drugs inside the nanofibers [12, 13]. One way to 
eliminate the burst release is post-treatment of membranes applied after 
electrospinning. The ones generally used for electrospun membranes are cross-
linking or chemical modifications. Unfortunately, both types of post-treatments have 
an inevitable problem of reduced biocompatibility [14, 15]. Another way of 
eliminating the burst release is using coaxial electrospinning technique for 
encapsulating the drugs inside the core of the core-shell structured nanofibers [16]. 
 
Coaxial electrospinning is superior to the usage of post-treatment steps as it 
decreases the complexity of the process and eliminates the potential damage that 
could be caused by post-treatment. On the other hand, the shell solution used in 
traditional coaxial electrospinning should be highly electrospinnable and have 
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enough viscosity for overcoming the interfacial tension between core and shell fluids 
[13]. 
 
Recently, a modification was made on traditional coaxial electrospinning, where 
dilute polymer solutions or organic solvents were used as shell fluids despite being 
unspinnable. Literature review reveals that, firstly organic solvents were used as shell 
fluid in order to control the nanofiber diameters [17, 18]. Next, dilute polymer 
solutions were used as shell fluid for producing a sustained drug release membrane. 
The model drug chosen (ketoprofen) in those studies was hydrophobic, miscible in 
the solvents and had good compatibility with the chosen polymers (zein and cellulose 
acetate) [19, 20]. Compatibility refers to the interactions between the drug and the 
polymer which do not cause any alteration in the chemical structure of the polymer 
or the drug. As every drug has different chemical and physical properties, it is 
impossible to produce a drug release membrane from a particular polymer which will 
be suitable for carrying all kinds of drugs [21]. 
 
In this research, modified coaxial electospinning was used for controlled release of a 
hydrophilic drug, ampicillin, which is known to have low compatibility with the 
chosen polymer, polycaprolactone. The results of this research have shown that, the 
application area of modified electrospinning in controlled release could be expanded 
to polymers and drugs with low compatibility. 
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2. LITERATURE REVIEW 
2.1. Controlled Release Principles 
 
Controlled drug release is one of the most rapidly advancing areas in science. 
Knowledge of biology, chemistry and material science is essential for working in this 
field. The controlled drug release systems are generally more advantageous than the 
conventional dosage forms as they have improved efficacy and reduced toxicity. 
Synthetic polymers are often used in those systems as drug carriers. The common 
denominator of controlled release systems is to improve the effectiveness of drug 
therapy. Compatibility between a drug and its carrier (polymers, liposomes etc.) is 
one of the essential factors, which influence the effectiveness of controlled drug 
delivery systems. Primary interactions refer to strong bonds such as ionic, covalent 
and metallic bonds [22]. Compatibility mainly refers to secondary interactions 
between drugs and their carriers. They are weaker as compared to secondary 
interactions. There are several types of it [21, 23]: 
 
Ionic interactions: It happens between ions or molecules with full permanent 
charges that arise from the attraction between a cation (positively charged ion) and 
an anion (negatively charged ion).  The bonds between them cannot be considered 
covalent as the electrons are not shared.  
 
Van der Waals forces: They are caused by non-uniform charge distributions on 
different atoms. The momentary random fluctuations in the electron distributions of 
an atom result in formation of a dipole. It includes London dispersion force, dipole-
induced dipole interaction and dipole-dipole interaction. Dipole-dipole interaction is 
the one, which happens between permanent dipoles in molecules. Dipole-induced 
dipole interaction is the one, which occurs between a non-polar molecule without 
permanent dipole and a molecule with a permanent dipole. In this type of interaction, 
a non-polar molecule becomes “induced” dipole upon polarization toward or away 
from a permanent dipole molecule. Finally, London dispersion force is the one that 
occurs between two induced dipoles. 
4  
 
Hydrogen bonding: It is a special kind of a dipole-dipole attraction that occurs 
between a highly electronegative atom (sulfur, oxygen, fluorine, or nitrogen atom) 
and hydrogen atom which is partially positive.    
 
Hydrophobic interactions: It takes place between nonpolar molecules, which do not 
contain a dipole moment or any ions. It is the tendency of nonpolar molecules to 
aggregate in aqueous solution where water molecules are excluded [23]. 
 
Drug release in the systems can be controlled temporally, spatially or both. The 
temporal control is achieved by protection of drug molecules against being quickly 
dissolved inside the aqueous environment of the patient. It involves inhibition of 
drug diffusion or delay of drug dissolution. Extended duration of release is beneficial 
if drugs that are rapidly metabolized and eliminated from the body are used. The 
spatial control on the other hand, is achieved by targeting the release of the drug to a 
certain site within the body. It can simply be done by implanting the drug release 
system topically [24]. Tissue scaffolds can be appropriately utilized as drug delivery 
systems. These scaffolds can facilitate the delivery of drugs while helping tissue 
growth and providing structural support [25]. For obtaining temporal and spatial 
control, controlled release mechanisms should be investigated thoroughly. 
 
2.2. Controlled Release Mechanisms 
 
Several mechanisms are involved in the release process. Understanding those 
mechanisms and identifying the main parameters affecting them are important for 
designing drug delivery systems. During the drug release process, usually more than 
one mechanism is involved. Moreover, during different stages, different mechanisms 
might dominate [26]. Those mechanisms can be degradation of covalent bonds, 
swelling, reversible drug–polymer interactions or diffusion [27]. 
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2.2.1. Diffusion-controlled release 
 
If the matrix used for drug release is porous and the molecular dimensions of the 
drug is much smaller than the pore sizes, the diffusion coefficient plays significant 
role. On the other hand, if the matrix is non-porous or the pore sizes are small, drug 
diffusion coefficient decreases due to increased drug diffusion path length.  
 
If the system includes a drug encapsulated inside a polymer and the system is in 
steady state, Fick's first law of diffusion can be used for describing the release profile 
through the membrane (see Appendix for derivation): 
 
J = −  D × 
dC
dx
 
 
where J (mol/(m
2
s)) is the flux of the drug, D (m
2
/s) refers to the diffusion 
coefficient, x (m) is the position and C (mol/m
3
) is the concentration of drug. 
 
If the system includes a drug entrapped inside a polymer, the drug is uniformly 
dispersed, and the drug concentration changes with time, Fick's second law of 
diffusion can be used for describing the release profile (see Appendix for derivation) 
[27]:  
 
𝜕𝐶
𝜕𝑡
= 𝐷
𝜕2𝐶
𝜕𝑥2
  
 
where x (m) is the position, D (m
2
/s) refers to the diffusion coefficient, t (s) is time 
and C (mol/m
3
) is the concentration of drug [27]. 
 
If the drug release rate from a system does not depend on its concentration, zero 
order kinetics equation can be used. The zero order drug release equation is (see 
Appendix for derivation) [28]:  
 
(2.1) 
(2.2) 
(2.3) 
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 C = C0 + K0t  
 
Where Q (mol/m
3
) is the amount of released drug, Q0 (mol/m
3
) refers to the initial 
amount of drug inside the medium (which is usually zero), K0 (mol/(m
3
s)) refers to 
the zero order release constant and t (s) is the time [28]. 
 
If the drug release rate from a system depends on its concentration, first order 
kinetics equation can be used. The first order drug release equation is (see Appendix 
for derivation) [29]:  
 
log(C) = log(C0) + Kt/2.303 
 
Where Q (mol/m
3
) is the amount of released drug, Q0 (mol/m
3
) is the initial amount 
of drug inside the medium, t (s) is the time and K (s
-1
) refers to the first order release 
constant [29]. 
 
Higuchi equation can be used for describing the release profile by diffusion (see 
Appendix for derivation) [30]: 
 
𝑀𝑡
𝑀∞
 = 𝐾𝐻 × 𝑡
1/2 
 
Where Mt (mol/m
3
) is the amount of drug released up to a certain time t (s), M∞ 
(mol/m
3
) refers to the final amount of drug released and KH (s
-1/2
) is Higuchi constant 
[30]. 
 
Later, Korsmeyer-Peppas equation was proposed for describing the release profile by 
diffusion: 
 
𝑀𝑡
𝑀∞
 = 𝑘 × 𝑡𝑛 
 
(2.6) 
(2.5) 
(2.4) 
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Where Mt (mol/m
3
) is the amount of drug released up to a certain time t (s), M∞ 
(mol/m
3
) refers to the final amount of drug released; n is the release exponent 
indicating the mechanism of drug release and k (s
-n
) is a structural/geometric constant 
for a certain system. There are different n values for drug release matrices with 
distinct release mechanisms and geometries [27]. The assumptions for the application 
of the Peppas equation are homogenously distribution of the drug on the carrier 
matrix, perfect sink conditions and constant diffusivity [20, 31].  
 
Several factors affect the rate of drug release controlled by diffusion. The first one is 
the presence of primary or secondary interactions between the drug and the polymer. 
The second one is how easy the medium can penetrate the matrix. The final one is 
drug dissolvability in the release medium [32]. 
 
2.2.2. Swelling-controlled release 
 
Polymers used in drug delivery systems might have a swelling-driven phase 
transition from a glassy state to a rubbery state. In the rubbery state, the drug 
molecules diffuse rapidly; however, in the glassy state the drug molecules are 
immobile. If such a system is present, the release profile depends on the rate of gel 
swelling. If the system is diffusion-controlled the time-scale of drug diffusion is the 
rate-limiting, on the other hand, if the system is a swelling-controlled polymer, then 
the relaxation (λ) is the rate limiting step.  
 
If both diffusion-controlled and swelling-controlled release is present, a modification 
of Peppas equation can be used [27]:  
 
𝑀𝑡
𝑀∞
= 𝑘1𝑡
𝑚 + 𝑘2𝑡
2𝑚 
 
In the equation, Mt (mol/m
3
) is the amount of molecule released up to any time t (s), 
M∞ (mol/m
3
) is final amount of molecule released, k1 (s
-m
), k2 (s
-2m
) and m are 
(2.7) 
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constants; 𝑘1𝑡
𝑚 represents diffusion contribution and 𝑘2𝑡
2𝑚 represents polymer 
relaxation contribution to the release profile [27]. 
 
2.2.3. Chemically-controlled release 
 
Diffusion and swelling controlled release mechanisms are mainly for drugs that have 
the same polarity as the medium which is generally aqueous. If the drug does not 
dissolve in the release medium, the primary driving force for drug release is 
considered to be chemically controlled degradation of the polymer [32]. 
 
Chemically-controlled delivery can be further divided into two types: 
 
Kinetic-controlled release: in this mechanism, diffusion is assumed to be negligible 
and polymer degradation is the rate-determining step 
 
Reaction-diffusion-controlled release: in this mechanism diffusion is not 
negligible. Both diffusion and reaction is included in the model [27]. 
 
Hopfenberg equation can be used for describing the release profile by matrix erosion. 
It can be used for the release profile from surface eroding cylindrical matrices with 
an initial dimension a0 [27]: 
 
𝑀𝑡
𝑀∞
= 1 −  (1 −
𝑘𝑎𝑡
𝐶0𝑎0
) 
 
where, Mt (mol/m
3
) is the amount of molecule released up to any time t (s), M∞ 
(mol/m
3
) is final amount of molecule released. n is a geometrical factor which is 2 
for cylindrical shape and 3 for spherical shape, C0 is the drug concentration and ka is 
the degradation constant [27].  
 
(2.8) 
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2.3. Electrospinning 
 
Electrospinning is one of the methods used for fabricating fibrous drug release 
systems. It uses electric force in order to draw charged threads of polymer solutions 
up to nanoscale fiber diameter. The process does not need any further wet-chemical 
treatment or high temperature for the formation of nanofibers [1]. 
 
2.3.1. Working Principle of Electrospinning 
 
In this method, a high voltage is applied to a liquid droplet. The liquid droplet 
consists of a polymer solution or polymer melt. The voltage should be high enough 
so that electrostatic repulsions (between like charges inside the solution) and 
electrostatic attraction (between the oppositely charged collector and liquid droplet) 
can overcome the surface tension. This will result with Taylor Cone formation from 
a rounded meniscus on the needle tip. From the Taylor cone, a fiber jet is ejected and 
the solvent, if involved, evaporates during the travel of the jet. As a result, solid 
polymer nanofibers are deposited on the collector. Straightforward production of 
biomaterials at this scale caused an interest in electrospinning in tissue engineering 
and drug delivery applications [33, 34].  
 
In Figure 2.1, a vertical setup of an electrospinning system is shown. The 
components of the system include: 
 
Voltage supply: The applied voltage is adjusted with the voltage supply. 
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Grounded target (also called the collector): It is where the fibers are collected. It 
should be made from a conductive material. 
 
Figure 2.1. Schematic illustration of electrospinning setup 
 
Syringe: The polymer solution is drawn into the syringe. Then, it is placed inside a 
syringe pump which automatically adjusts the pumping force for a particular flow 
rate. The Taylor cone and the liquid jet are formed when the electrospinning process 
begins [2]. 
 
2.3.2. Parameters Affecting Electrospinning 
 
There are three types of parameters affecting the electrospinning process: Process 
parameters, Material parameters and Ambient parameters. 
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2.3.2.1. Process Parameters 
 
Process parameters affecting the quality of fibers are: 
 
Electrical Potential: Firstly, the voltage applied to the liquid droplet effects the 
formation of Taylor cone. When it is lower than the critical voltage, Taylor cone and 
the jet is not formed properly. When it is much higher than the critical voltage, the 
Taylor cone becomes unstable and bead formation occurs. Secondly, it was observed 
that fiber diameter decreases with increasing voltage [35]. 
 
Flow Rate: If flow rate is too high than plugging of needle tip can be observed due 
to excess polymer solution. Also, it should be sufficient for fiber production [35]. 
 
Distance between the capillary and collection screen: The decrease in fiber 
diameter is observed with increase in distance. However, if beads are present, 
increase in distance caused larger beads on the fibers [36]. 
 
Needle gauge: It affects the Taylor cone formation parameters (critical voltage and 
tip to collector distance) [37]. 
 
Type of the collector: There are several types of collectors, which act as the 
conductive surface for collecting the fibers. Plane plate collector, drum rotatory 
collector and grid type collector are some of them. It was found that the shape and 
size of the collector has an effect on alignment, diameter and structure of the 
nanofibers produced during electrospinning [38]. 
 
2.3.2.2. Material Parameters 
 
Polymer concentration: increase in polymer concentration is found to increase the 
diameters of the fibers that are produced. Also, it was found that formation of fibers 
can be blocked due to the high viscosity of the solution at high polymer 
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concentration. If the concentration of the solution is too low, nanoparticles were 
observed instead of nanofibers [35]. 
 
Molecular weight of the polymer: it was observed that fiber diameter increases 
with molecular weight of the polymer. Also, when low molecular weight was used, 
the fibers are found to have circular cross-section. On the other hand, at high 
molecular weights flat fibers were observed [39]. 
 
Also, viscosity, conductivity and surface tension of the solution all affect the 
electrospinning process and they should be between certain ranges for stable Taylor 
cone formation. These ranges change for different polymer solutions. Viscosity and 
surface tension can be regulated by using different ratios of solvents. Conductivity is 
mostly affected by solvent and polymer types [40, 41].  
 
2.3.2.3. Ambient Parameters 
 
Ambient parameters affecting the fiber quality are humidity, temperature and air 
velocity in the chamber. Evaporation rate of the solvent increases with increase in 
temperature, on the other hand, viscosity decreases with increase in temperature. 
Effect of humidity on fiber diameter depends on the chemical and molecular 
interactions of the polymer and solution. In general ambient conditions should all be 
kept constant for uniform fiber production [42]. 
 
2.3.3. Types of Electrospinning 
 
Single Electrospinning: It is the conventional electrospinning where one nozzle and 
one syringe pump is used. 
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Coaxial Electrospinning: In this type of electrospinning a core–shell nozzle is 
attached to a supply of two polymer solutions. One syringe pump is for shell polymer 
solution and the other is for core polymer solution. As a result, its setup is more 
complicated than single electrospinning setup which includes a single nozzle and 
syringe pump.  
 
Figure 2.2. Schematic illustration of (A) emulsion electrospinning and (B) coaxial 
electrospinning (modified from reference [43]) 
 
 
Emulsion Electrospinning: It is demonstrated that production of core–shell polymer 
nanofibers is also possible by using single electrospinning setup. For this, an 
emulsion of two polymer solutions should be prepared as a working liquid [44]. In 
figure 2.2, emulsion electrospinning and coaxial electrospinning are schematically 
illustrated. In emulsion electrospinning, a single nozzle is used; however, in coaxial 
electrospinning a coaxial nozzle with two capillaries is needed. The core and shell 
solution of emulsion electrospinning should not be miscible so that they can form the 
emulsion. On the other hand, for coaxial electrospinning both miscible and 
immiscible core and shell solutions can be used. 
 
Melt Electrospinning: In this type, polymer melts are used instead of dissolving the 
polymers inside volatile solvents [45]. Although it is an alternative to solution 
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electrospinning, it has generally caused the formation of fibers with diameters of tens 
of microns [46, 47].  
 
2.4. Coaxial Electrospinning 
2.4.1. Working Principle of Coaxial Electrospinning 
 
The general set up of coaxial electrospinning is quite similar to that used for single 
electrospinning. The modification is made in the spinneret. A smaller inner capillary 
is inserted into a bigger capillary to obtain the co-axial configuration. The two 
capillaries are adjusted to fit concentrically. The outer capillary is connected to the 
syringe containing the shell solution, and the inner one is attached to a second 
syringe containing the core solution [13]. Two polymer solutions are coaxially 
electrospun through different channels in order to synthesize core-shell structured 
nanofibers [48]. Core and shell solutions are distinctly prepared and put into different 
syringe pumps. The flow rates of each solution can be adjusted during the process for 
formation of stable Taylor cone. All the other features (voltage, collector-needle 
distance etc.) are adjusted similar to what is done in traditional single electrospinning 
setup. The arrangement of the setup can be horizontal or vertical [49]. 
 
A typical coaxial electrospinning setup is illustrated in Figure 2.3. It can be seen 
from the figure that the general components of the setup (high voltage supply, 
grounded electrode) are similar to single electrospinning but the spinneret is more 
advanced due to the presence of two different capillaries [13].  
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Figure 2.3. Schematic illustration of coaxial electrospinning setup (modified from 
reference [13]) 
 
 
For coaxial electrospinning, many different polymers were used by other 
investigators. Those polymers include natural materials, synthetic materials, and 
synthetic biodegradable polymers. The electrospinning products were then used as 
drug delivery devices, tissue engineering scaffolds and wound dressings. In addition 
to biomedical applications those products were also used as liquid, gas, and 
molecular filters, in photovoltaic, LCD devices, thermomechanical and biochemical 
sensor devices [13]. 
 
Interaction between the core and the shell solutions is essential for coaxial 
electrospinning.  Firstly, the solvent in both the core and shell solutions should not 
precipitate the polymer from the other one when the two solutions meet at the needle 
tip [50]. Secondly, the interfacial tension between the core and shell solutions should 
be as low as possible so that the compound Taylor cone will be stable [51]. In Figure 
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2.4, a drawing for illustration of Taylor cone formation on the coaxial needle tip is 
shown. 
 
 
Figure 2.4. Taylor cone formation in coaxial electrospinning (modified from the 
reference [13]) 
 
2.4.2. Coaxially Electrospun Nanofibers for Drug Delivery Applications 
 
Core and shell structure of the fibers provides a great potential to synthesize a single 
product with unique properties that are difficult to obtain from separate 
electrospinning of the same materials. It is similar to blending of materials but 
different from it as the two materials maintain their separate features. It can also be 
seen as a one-step method for obtaining a coated product. 
 
Production of core-shell nanofibers via electrospinning may be considered as a 
revolutionary development for biomedical applications. Many studies were 
performed where core shell nanofibers were produced involving variety of materials 
with novel structures for new applications. By using those materials, sustained 
delivery of the drugs can be achieved with core-shell structured fibers as carriers 
[52]. 
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The biomedical applications of core-shell nanofibers besides controlled drug release 
are [53-55]: 
 
1. Isolation of an unstable component for protecting it from decomposition under a 
highly reactive environment. 
 
2. Reinforcement of a material for improving its mechanical properties. 
 
3. Scaffold production for tissue engineering where a less biocompatible polymer is 
surrounded by a biocompatible one.  
 
In addition to controlled release of drugs, coaxially electrospun nanofibers can also 
be used for one-step encapsulation and controlled release of plasmid DNA, peptides 
and growth factors and other biomolecules which are involved in tissue regeneration. 
The process eliminates the damages caused by direct contact of the agents with harsh 
conditions or organic solvents. The shell layer acts as a barrier by preventing the 
burst release of the molecules inside the core. Release of the encapsulated agents is 
modulated by varying the composition and structure of the nanofibers.  
 
In one of the related studies performed by Huang et al., the release profile of two 
drugs (resveratrol and gentamycin sulfate) were investigated. PCL was used as the 
shell solution and two drugs (gentamycin sulfate in water and resveratrol in ethanol) 
were used as the core solutions. Drug release profiles of the coxially electrospun 
products was in a sustained manner without the burst release [56]. Another research 
performed by Jiang et al. found that the lysozyme released from coaxially 
electrospun core/shell fibers is bioactive and could maintain its structure [57]. The 
release profile of proteins were further modified by adding PEG to the shell solution. 
As the flow rate of the core solution increased, the loading efficiency and release rate 
of proteins increased, too [58]. Moreover, Saraf et al. was able to achieve non-viral 
gene delivery with coaxial electrospinning [59] and Liao et al. used coaxial 
electrospinning for sustained viral gene delivery. These are some of the promising 
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works that was done with coaxially electrospun nanofibers which can be used in 
local drug delivery, tissue engineering and wound healing applications [60]. 
 
2.4.3. Modified Coaxial Electrospinning 
 
Coaxial electrospinning was previously done with both fluids being electrospinnable 
or at least the shell fluid was preferred to be electrospinnable [51, 58, 61]. Modified 
coaxial electrospinning is a recently developed technique where an unspinnable shell 
solution and a spinnable core solution are used. Previously, a modified process based 
on coaxial electrospinning was done. In this process only the organic solvents were 
used as shell fluid. In that study, the modified process was mainly used to manipulate 
the diameters of the nanofibers. It was found that with a mixture of solvents as the 
shell fluid, the nanofiber quality can be improved effectively. The improved features 
include fiber size, size distribution, fiber textures and surface smoothness [62]. This 
process was also used for production of poly-acrylonitrile nanofibers as carbon 
nanofiber precursors where again unelectrospinnable solutions were used as shell 
fluids [63-65].  
 
After verifying that unspinnable solvents can be used as shell fluids, dilute polymer 
solutions were also used as shell fluids. This type of coaxial electrospinning was 
particularly used for controlled release studies for production of zero-order drug 
release membranes. In one research, an unspinnable dilute zein solution was used as 
shell fluid and an electrospinnable zein/ketoprofen mixture was used as the core 
fluid. In another study, ketoprofen (KET) was chosen as a model hydrophobic drug 
and cellulose acetate was used in the dilute shell solution and in the core solution as a 
mixture with KET. In both studies, the chosen drug (Ketoprofen) was found to have 
a good compatibility with the polymers. Moreover, it was easily dissolved in the 
organic solvents and was fully mixed with the polymers inside the core solution. 
These two features helped to eliminate the burst release in addition to the main effect 
of the shell layer of nanofibers [19, 20]. 
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In this research, modified coaxial electospinning was used for controlled release of a 
a hydrophilic drug (ampicillin), which is known to have a low compatibility with the 
polymer (polycaprolactone). Moreover, a partially electrospinnable shell solution 
(4% w:v PCL), was used instead of a fully unspinnable one.  
 
2.5. Characterization Techniques 
 
The characterization techniques used in this research are scanning electron 
microscopy, optical microscopy, Fourier transform infrared spectroscopy and UV-
Vis spectroscopy. 
 
2.5.1. Scanning Electron Microscopy (SEM) 
 
Scanning electron microscope (SEM) is the type of electron microscope, which uses 
a focused beam of electrons for the production of sample images with high 
magnification. The electrons of the microscope interact with atoms on the sample 
surface. As a result, various signals are produced and they are detected. The surface 
topography of the sample is analyzed with the help of those signals. The resolution of 
SEM can be as low as 1 nanometer. The lenses of SEM (condenser and objective 
lenses) are used for focusing the electron beam to a particular spot.  
 
2.5.2. Optical Microscopy 
 
Optical microscope (also called light microscope) magnifies the image of the sample 
by using visible light and a set of lenses. It consists of ocular lenses, objective lenses, 
light source, focus knobs (for fine adjustment and coarse adjustment), stage, 
diaphragm-condenser and finally the mechanical stage. The magnification of an 
optical microscope is the product of the powers of the ocular and the objective lens. 
Focus knobs are for moving the stage in order to focus on the image. A condenser 
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and diaphragm are used to concentrate light from its source so that it is focused onto 
the sample. 
 
2.5.3. Fourier Transform Infrared Spectroscopy (FTIR) 
 
Fourier transform infrared spectroscopy (FTIR) spectrometer is able to collect high 
spectral resolution data for a wide spectral range. It shines a beam of light with many 
frequencies at once in order to measure the absorption of the beam by the sample. 
The beam with different combinations of frequencies is given many times and the 
absorptions of different wavelengths are inferred by the computer. 
 
 
2.5.4. Ultraviolet–visible spectroscopy (UV-Vis Spectroscopy) 
 
Electromagnetic radiation (for example visible light) is considered as a wave 
phenomenon and it is characterized by a wavelength or frequency. The distance 
between adjacent peaks refers to the wavelength. On the other hand, frequency is the 
number of wave cycles that pass through a certain point per time. The UV-Vis 
spectrometer scans all the component wavelengths over a short period time. The 
visible light region is from 400 to 800 nm and the UV region scanned is from 200 to 
400 nm. The absorbance is displayed on the vertical axis and the wavelength is 
displayed on the horizontal axis. λmax is the wavelength of maximum absorbance 
and it is a characteristic value of samples.  
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3. MATERIALS AND METHODS 
3.1. Materials 
 
Polycaprolactone (catalog #: 440744, Mw: 80000 DA), PBS tablets (catalog #: 
P4417), Crystal Violet (catalog #: 61135) and methanol (catalog #: 34885) were 
obtained from Sigma Aldrich (USA). Chloroform was obtained from Merck (catalog 
#: 102431). Ampicillin sodium salt (catalog #: A0839) was purchased from 
AppliChem (USA). Ampicillin is an antimicrobial agent which is a part of penicillin 
group of beta-lactam antibiotics. It is able to penetrate a broad spectrum of bacteria 
by inhibiting the enzyme which synthesizes the bacterial cell wall [32]. The 
molecular weight of PCL was chosen based on its suitability for drug release 
applications as reported in the literature [66]. 
 
3.2. Methods  
3.2.1. Optimization Studies for Core and Shell Solutions 
 
A preliminary study was performed prior to the production of drug release 
membranes in order to determine and optimize certain parameters of production. The 
investigated parameters were applied voltage, needle tip to collector distance and 
shell polymer concentration. In the first part, optimization of electrospinning system 
parameters was carried out. Among five system parameters, needle gauge and 
collector type was kept constant. Among the remaining parameters optimization of 
tip to collector distance and the applied voltage was carried out at constant core 
solution flow rate.  For determining these parameters, optimization of the flow rates 
of core and shell solutions were performed during the synthesis of membranes. In the 
second part, the concentration of shell solution was determined.  For this purpose, the 
electrospinnability of PCL solutions with different PCL concentrations was tested. 
Two features were paid attention in this part. One of them is the electrospinnability 
of the solution and the other one is polymer concentration. Among those properties, 
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the solution with highest concentration while not being fully electrospinnable was 
chosen. All experiments were carried out at room conditions.  
 
In this research, the solvent ratios for all electrospinning solutions were kept constant 
at chloroform:methanol (9:1, by volume) [32].  
 
3.2.1.1. Optimization of Electrospinning Parameters  
 
In this part, applied voltage range and distance between needle tip and the collector 
were determined by using single electrospinning of the PCL/Ampicillin solution. 
Those two parameters were kept constant throughout the experiment after being 
optimized. 
 
For the production of the electrospinning solution, 0.1 gram of ampicillin was 
dissolved in 0.2 ml of Methanol. On the other hand, 0.5 gram Polycaprolactone was 
dissolved in a solvent mixture containing 4.5 ml Chloroform and 0.3 ml Methanol for 
two hours. After both PCL and Ampicillin were dissolved, two solutions were mixed 
to prepare the final solution containing 10% (weight:volume) PCL and 2% w:v 
Ampicillin with 9:1 v:v chloroform:methanol as solvent. This solution was mixed for 
another hour.  
 
Table 3.1. Electrsopinning parameters investigated in the preliminary studies 
Preliminary Studies Part 1 Preliminary Studies Part 2 
Tip to Collector Distance Applied Voltage PCL Concentration 
9-10 cm 8-12 kV 3-5 % (w:v) 
 
In the literature, tip to collector distance was kept 8 cm [32]. In this research; the 
distance was tried to be increased. For that purpose, the distances was varied in the 
range 8-10 cm by 1 cm increments. After the optimal distance was determined, the 
voltage values between 8-12 kV were also tested in order to find out the optimal 
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voltage. The optimization process was carried out by keeping the core solution flow 
rate 1 ml/h. 
 
3.2.1.2. Electrospinnability of Solutions with Different PCL Concentrations 
 
In this part, PCL solutions with three different PCL concentrations were prepared 
and their electrospinnability was observed. A total of 0.15, 0.20 and 0.25 grams of 
PCL were dissolved in 0.5 mL Methanol and 4.5 ml Chloroform for an hour in order 
to produce 3%, 4% and 5% w:v PCL solutions, respectively. For the electrospinning 
of the solutions, parameters that were determined at the optimization part were used. 
The applied voltage was kept 12 kV and the tip to collector distance was kept 9 cm. 
The flow rate of all the solutions was 1 ml/h. 
 
In order to observe the electrospinnability of the solutions, the samples were 
collected on microscope slides which were put on the 15x15 cm
2
 Aluminum 
collector. The samples were observed under optical microscope (Nikon Eclipse, 
LV100).  
 
On the basis of this data obtained in preliminary observations, the results were 
evaluated and the optimum process parameters were clarified for further studies.  
 
3.2.2. Coaxial Electrospinning and Production of Membranes 
 
In the experiment, stainless steel co-axial nozzle (Inovenso, Turkey) was used for the 
formation of core-shell structures. It has two inputs for two different fluids. The input 
for the shell fluid is on the left and the input for the core fluid is on the top of it. The 
two fluids are finally united on the bottom tip (Figure 3.1). The inner diameter of the 
nozzle tip is 0.7 mm and the outer diameter is 1.2 mm (Figure 3.2). 
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Figure 3.1. Coaxial electrospinning nozzle (A) Side view (B) Bottom view 
 
 
 
 
Figure 3.2. Sketch of a coaxial nozzle 
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Table 3.2. Flow rates and compostions used for production of samples 
  
 
Before electrospinning, core and shell solutions were prepared separately. The core 
solution was a 10% w:v PCL solution containing 2% w:v ampicillin. It was the 
solution used during the optimization process and its preparation is explained in 
section 3.2.1.1. The shell solution was a 4% PCL solution, the preparation of which 
is explained in section 3.2.1.2. The solutions were drawn into syringes. 
 
Two syringes containing core and shell solutions were separately placed into two 
syringe pumps. The diameter of the syringes was 12.06 mm. For production of CS1 
membranes, the core and shell flow rate were both kept at 0.5 ml/h. For production 
of CS2 membranes, the core flow rate was kept at 0.5 ml/h and the shell flow rate 
was kept at 0.6 ml/h. For single electrospinning of the core (CR membrane), the shell 
flow rate was kept at 0 ml/h and core flow rate was kept at 1 ml/h. For single 
electrospinning of shell solution, the shell flow rate was kept at 1 ml/h and core flow 
rate was kept at 0 ml/h (Table 3.1). 
Fiber Name Composition Flow Rate (ml/h) 
Core Fluid Shell Fluid Core Shell 
CS1 (Core/Shell 1) 10 % (w:v) PCL 
2% (w:v) ampicillin 
4 % (w:v)PCL 0.5 0.5 
CS2 (Core/Shell 2) 10 % (w:v) PCL 
2% (w:v) ampicillin 
4 % (w:v) PCL 0.5 0.6 
CR (Core) 10 % (w:v) PCL 
2% (w:v) ampicillin 
Not Present 1.0 - 
Shell Not Present 4 % (w:v) PCL - 1.0 
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The distance between nozzle tip and the collector was kept 9 cm and the voltage was 
kept 12 kV. These parameters were determined by the preliminary work described in 
section 3.2.1.1. The schematic representation of the process is illustrated in Figure 
3.3.  
 
 
Figure 3.3. Schematic of the process of formation of core-shell nanofibers (modified 
from reference [67] 
 
For observation of core-shell structure under Optical Microscopy, the process was 
run for 30-60 seconds. The samples were collected on microscope slides which were 
attached to the Aluminum collector. 
 
Core solution was stained with Crystal Violet for one time in order to take the 
photograph of the Taylor cone. In other studies, no dye was used. For other 
characterization techniques and drug release studies, the electrospinning was carried 
out for 4 hours and a 15x15 cm
2 
Aluminum foil was used as the collector. Figure 3.4 
is a photograph of the system which was used in this study. 
 
Taylor Cone 
formation 
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Figure 3.4. Photograph of coaxial electospinning system used in the study 
 
3.2.3. Characterization of the Membranes 
 
The morphology of the membranes was observed under environmental scanning 
electron microscope (FEI-Quanta 200 FEG, ABD). Prior to the examination, the 
samples were sputter-coated with gold. Images with different magnification were 
taken (2500x, 5000x, 20000x, 50000x) 
 
The average fiber diameter of three different samples was found by measuring their 
diameters from SEM images at 50 different places for each sample using Image J 
software (NIH, MD, USA).  
 
The core-shell structures of the nanofibers collected on microscope slides were 
observed under optical microscope (Nikon Eclipse, LV100). 
Shell 
Solution 
Core  
Solution 
Coaxial 
Nozzle 
Collector 
Syringe 
Pump 
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The compatibility between components of the membranes was investigated by 
Attenuated total reflectance Fourier transform infrared (ATR-FTIR) analysis. It was 
performed with a FTIR spectrometer (Perkin Elmer Spectrum, 100, USA) from 650 
to 4000 cm
−1
. 
 
3.2.4. Drug Release Studies 
 
In vitro drug release profile of ampicillin from the electrospun membranes was 
examined by measuring the ampicillin concentration released into phosphate 
buffered saline (PBS, pH: 7.4) solution with UV-VIS spectrophotometer (Hitachi U-
5100, Japan).  
 
Firstly, in order to measure the ampicillin release profile, maximum absorbance of as 
purchased ampicillin in PBS was studied and it was found to occur at the wavelength 
of 325 nm. The absorption of solutions with predetermined drug concentrations was 
measured in order to draw a calibration curve based on this wavelength. The 
resulting calibration curve is shown in Figure 3.5. It was later used to calculate the 
ampicillin concentrations released from the membranes into the PBS solutions. 
 
Secondly, the membranes were kindly separated from the aluminum foil. Then, they 
were cut to form squares with dimensions of 1.5x1.5 cm
2
 which weighed 100 mg on 
average. They were kept in desiccator overnight to remove any remaining solvent.  
 
A PBS tablet was dissolved in 100 ml of distilled water for preparing the PBS 
solution (pH: 7.4). A total of 4 ml of PBS was poured into 4 wells of a 12-well plate. 
The samples were immersed into 3 of the wells, the remaining one was used as 
negative control. The 12 well plate was placed inside a 37°C orbital shaking bath 
(MAXQ 4450 Thermoscientific) and the shaking speed was adjusted to be 50 rpm. 
At certain time intervals (1, 2, 4, 8, 24, 48, 72 and 96 hours) 1 ml of sample solution 
was taken and replaced with 1 ml of stock PBS solution. The absorption values of all 
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the sample solutions taken for different time intervals were determined by the UV-
VIS spectrophotometer at the wavelength of 325 nm.  
 
 
 
Figure 3.5. Calibration curve for ampicillin concentration in PBS 
 
 
Finally, the drug encapsulation efficiencies of three membranes were found. 10 mg 
of each membrane was dissolved in 5 ml chloroform. After they are fully dissolved, 
5 ml of PBS was added and the solution was vortexed for 45 minutes. Following the 
phase separation of chloroform and PBS, the concentration of ampicillin inside the 
PBS was found with UV-VIS spectrophotometer at the wavelength of 325 nm. Each 
experiment was repeated three times. 
 
3.2.5. Statistical Analysis 
 
SPSS 22.0 for Windows was used in statistical analysis. The fiber diameters and the 
drug encapsulation efficiencies of three membrane groups (CR, CS1, CS2) were 
compared. One-way ANOVA (analysis of variance) test followed by Tukey's HSD 
(honestly significant difference) test was employed for testing the significance. 
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Sample size was 50/group for testing fiber diameters and 3 for drug encapsulation 
efficiency. The data were shown as the mean ± SD and the p value (significance) for 
both tests was set as p < 0.05. 
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4. RESULTS AND DISCUSSION 
4.1. Results of the Preliminary Studies 
 
In the first part of the preliminary studies, optimization of the electrospinning 
parameters was carried out. In addition to obtaining a stable Taylor cone, the 
parameters that result in minimum plugging were also studied. Plugging is the 
aggregation of the polymer on the needle tip, which causes blocking of the fluid 
flow. Moreover, increasing tip to collector distance reduces the formation of fused 
fibers and results with finer fibers. For this purpose, three different distances, 8-10 
cm, were tested. For all distances a stable Taylor cone was obtained; however, the 
minimum plugging was observed for 9 cm tip to collector distance. When the 
distance was increased to 10 cm, the polymer on the tip blocked the fluid flow a few 
minutes after initiating the process. However, when the distance was 9 cm, plugging 
did not occur for a longer period (more than 10 minutes). 
 
Figure 4.1. Photograph of a stable Taylor cone 
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While keeping the distance 9 cm, different voltage values were tested. When the 
voltage was below 9 kV, Taylor cone did not occur properly and dropping of the 
solution was observed. Plugging was observed with all voltages after some time; 
however, minimum plugging happened when the voltage was 12 kV. When the 
voltage was above 12 kV, more than one jet was observed. As a result, 9 cm tip to 
collector distance and 12 kV applied voltage were chosen as working parameters in 
the next steps. In figure 4.1, a stable Taylor cone without plugging is shown when tip 
to collector distance was 9 cm, applied voltage was 12 kV and the flow rate was 1 
ml/h.  
 
In the second part of the preliminary studies, the electrospinnability of solutions with 
different PCL concentrations were tested. This was done in order to determine the 
concentration of shell solution, which will be used in drug release membrane 
production. Previously it was thought that only a highly electrospinnable shell 
solution could be used in coaxial electrospinning; however, a modified coaxial 
electrospinning technique was developed where a dilute unspinnable shell solution 
can be used. As this modified electrospinning technique was used in this study, a 
partially unelectrospinnable shell solution was preferred. It is known that, 
electrospinnability changes with polymer concentration. On the other hand, as the 
polymer concentration of shell solution increases, the coaxial fibers could be coated 
with a thicker shell layer. The shell layer was desired to be thick enough to prevent 
the burst release. For those purposes, a shell solution with highest PCL concentration 
without being electrospinnable was investigated. The optical images could be a good 
indicator for the electrospinnability of the solutions. If the image is only formed by 
micro/nanoparticles, it is understood that the solution was not electrospinnable. The 
images of fibers/particles produced from 3%, 4% and 5% PCL solutions with 50X 
magnification can be seen in Figure 4.2, Figure 4.3 and Figure 4.4, respectively.  
 
For the sample prepared from 3% PCL (w:v) solution, it can be seen from the optical 
microscopy image that only micro/nanoparticles were produced and it was not 
electrospinnable. 
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For the sample prepared from 4% (w:v) PCL solution, both micro/nanoparticles and 
micro/fibers with beads were produced. This sample was also not fully 
electrospinnable and it was chosen as the shell fluid. In Figure 4.5, another image of 
this sample with 100x magnification is shown. 
 
For the sample prepared from 5% (w:v) PCL solution, mainly fibers with beads were 
obtained. As this solution is fully electrospinnable, it was not chosen as the shell 
fluid. 
 
 
 
Figure 4.2.  Electrospinning product of 3% (w:v) PCL 
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Figure 4.3.  Electrospinning product of 4% (w:v) PCL 
 
 
Figure. 4.4. Electrospinning product of 5% (w:v) PCL 
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Figure 4.5. Higher magnification of 4% (w:v) PCL electrospinning product 
 
4.2. Taylor Cone Formation in Coaxial Electrospinning 
 
Formation of stable Taylor cone is essential in order to obtain membranes with fine 
and uniform nanofibers. For this purpose, the optimization process for obtaining a 
stable Taylor cone was carried out. In this process, effect of the flow rates of core 
and shell solutions on the formation of stable Taylor cone was investigated. In order 
to reduce complexity, all the other parameters were kept constant except the flow 
rates. On the basis of data obtained in preliminary studies, tip to collector distance 
was kept 9 cm and the voltage was kept 12 kV. The same collector was used for all 
experiments. (For the experiment where microscope slides were used, the slides were 
put on that collector.) The flow rate values, which resulted in stable Taylor cone, are 
listed on Table 4.1. 
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Table 4.1. Electrospinning parameters used for production of membranes 
Sample 
Name 
Composition Flow Rate Distance Applied 
Voltage Core  
Fluid 
Shell 
Fluid 
Core 
Fluid 
Shell 
Fluid 
CR 10 % (w:v) PCL 
2% (w:v) ampicillin 
4 % (w:v) 
PCL 
1 ml/h - 9 cm 12 kV 
CS1 10 % (w:v) PCL 
2% (w:v) ampicillin 
4 % (w:v) 
PCL 
0.5 ml/h 0.5 ml/h 9 cm 12 kV 
CS2 10 % (w:v) PCL 
2% (w:v) ampicillin 
Not 
Present 
0.5 ml/h 0.6 ml/h 9 cm 12 kV 
 
  
Figure 4.6. Formation of Taylor cone during coaxial electrospinning 
 
For production of core-shell nanofibers, when the shell flow rate was above 0.6 ml/h, 
the time was not sufficient for solvent evaporation and dropping of the fluid onto the 
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membranes occurred. This also resulted in destruction of previously formed fibers on 
the membrane. Moreover, it caused plugging on the needle tip and disturbed the 
Taylor cone. When the shell flow rate was below 0.5 ml/h, formation of more than 
one jet was observed on the needle tip. These jets are not desired because core and 
shell fluids should form a single jet at the end of the Taylor cone for formation of 
proper core-shell structure. This single jet was observed for the flow rates used to 
produce the samples, CS1 (Core/Shell 1) and CS2 (Core/Shell 2). The photograph of 
a stable Taylor cone is shown in Figure 4.6. The core solution was colored by Crystal 
Violet for showing the core and shell fluids separately on the photograph. It can be 
seen that the shell fluid successfully covered the core fluid and the Taylor cone 
formed on the tip of it. Moreover, it was observed that using dilute shell solutions 
resulted in less plugging on the needle tip. Plugging and blockage of needle tip 
happened more frequently during the electrospinning of the core alone (production of 
CR membranes). 
 
The formation of stable Taylor cone was not taken into account while the 
electrospinning of the shell alone, because it was not used in drug release studies. 
 
4.3. Morphology and Structure of Nanofibers 
 
The SEM images of three sample membranes CR, CS1 and CS2 are shown in Figure 
4.8, Figure 4.9 and Figure 4.10, respectively. The morphology of CS1 and CS2 
membranes were similar which both had a variation in fiber diameters (less uniform 
fiber distribution). On the other hand, for the single electrospinning of the core 
(Sample: CR), more uniform nanofibers were obtained. Nanofibers CR, CS1 and 
CS2 had average diameters of 702 ± 166 nm, 464 ± 214 nm and 567 ± 180 nm 
respectively. The p value of ANOVA test was smaller than 0,05 which suggested that 
one or more pairs of three samples have significantly different fiber diameters. From 
Tukey’s HSD test, all the p values were smaller than 0,05 which demonstrated that 
the diameters of all three samples were significantly different. The average fiber 
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diameter of CR was greater than both CS1 and CS2. Moreover, average fiber 
diameter of CS2 was higher than CS1 (Figure 4.7).  
 
Figure 4.7. Fiber diameters of the membranes (* denotes significant difference at p < 
0.5) 
 
Figure 4.8. SEM image of CR membrane with (a) 2500X, (b) 5000X, (c) 20000X 
and (d) 50000X magnification 
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The reason for the difference in fiber diameters is the fact that less solid solutes was 
exported from the nozzle due to the presence of dilute shell solution in CS1 and CS2. 
Production of CR membranes was carried out at core flow rate of 1 ml/h, while for 
production of CS1 and CS2 membranes the core flow rate was 0.5 ml/h. This 
resulted in less amount of PCL during the electrospinning of core-shell nanofibers. 
As a result, the fibers produced in this process were finer. When CS1 and CS2 were 
compared, the reason for CS1 having finer fibers is the fact that CS1 has less solid 
solutes due to its lower shell flow rate. 
 
 
Figure 4.9. SEM image of CS1 membrane with (a) 2500X, (b) 5000X, (c) 20000X 
and (d) 50000X magnification 
 
In CS1 and CS2 groups, presence of a non-uniform fiber distribution with very fine 
fibers standing apart from others were observed. For CS1, fibers with diameters even 
smaller than 100 nm can be seen in Figure 4.9. Those fibers are speculated to be 
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caused by the extra jets that might be present on Taylor cone. Those jets were 
especially seen when the flow rate was below 0,5 ml/h but they might have occurred 
rarely during the production of CS1 and CS2 membranes. It was previously stated 
that the instabilities during the formation of Taylor cone caused non-uniform fiber 
distribution and extra jet formation is an example of instability [68]. The low 
frequency of those fine fibers shows that these problems have happened for a short 
time and generally the process was successful without extra jet formation.  
 
 
Figure 4.10. SEM image of CS2 membrane with (a) 2500X, (b) 5000X, (c) 20000X 
and (d) 50000X magnification 
 
Moreover, nanofibers of all the samples had a rough surface morphology. One reason 
for this can be the low viscosity of the solutions. It was found earlier that fibers 
become smoother if the viscosity is increased [41]. This might be because of 
inadequate dissolution of PCL in the solvent mixture due to the low mixing time. It 
was also found in the literature that the vapor pressure of the solvent affects smooth 
fiber fabrication. It is stated that rough fiber production is observed when solvents 
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with low boiling points were used. Both chloroform and methanol used in this 
research have low boiling points [69, 70].  
 
 
Figure 4.11. SEM image of shell electorpinning with (a) 2500X and (b) 5000X 
magnification  
  
Figure 4.12. SEM image of a microparticle surface produced by shell electrospinning 
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Finally, the morphology of shell solution, which was electrospun alone, was 
examined (Figure 4.11). Both micro/nanofibers and micro/nanoparticles can be seen 
in Figure 4.11. On the other hand, no micro or nanoparticle was present on samples 
CS1 and CS2. The absence of micro/nanoparticles on those membranes proves that 
shell and core solutions were generally electrospun together while the core-shell 
structures were being produced. In case of the malfunctioning of the flow regime, a 
separation of core and shell streams could happen and the electrospinning of them 
separately should have caused the formation of at least some micro/nanoparticles on 
CS1 and CS2 membranes.  
 
In Figure 4.12, a 50000X magnification of a microparticle produced by shell 
electrospinning is shown. The rough surface morphology previously observed on 
samples CS1, CS2 and CR is present on microparticle surfaces, too. This observation 
can also be because of low viscosity, low voltage and solvent properties which were 
the reasons of rough fiber surface of samples CR, CS1 and CS2.  
 
By using optical microscopy the core-shell structure of the fibers were observed. Due 
to the limitations of optical microscopy, only the fibers with large diameters were 
examined. The core-shell structure observed for samples CS1 and CS2 are shown in 
Figure 4.13 and Figure 4.14, respectively. Although, those images do not belong to a 
typical nanofiber from the samples, they can be seen as indicators for the production 
of the core-shell structure. In the future, TEM images of the samples will be taken as 
proofs of core-shell structure. 
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Figure 4.13. Core-shell structure of CS1 membrane 
 
Figure 4.14. Core-shell structure of CS2 membrane 
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4.4. Compatibility of Components 
 
Compatibility refers to the secondary interactions between the polymer and the drug 
which slow down the drug release rate. In order to produce a nanofibrous membrane 
with minimum burst release, compatibility between the components is indispensable. 
Improvement of compatibility can be achieved via secondary interactions. 
Hydrophobic interactions, electrostatic interactions and hydrogen bonding are 
examples of these second order interactions. Hydrogen bonding occurs when a 
hydrogen atom bound to a highly electronegative atom (fluorine, oxygen or nitrogen) 
has an attraction to another highly electronegative atom, which is nearby [71]. PCL 
has oxygen atoms, which can be hydrogen bond acceptors and ampicillin has 
hydrogen atoms bound to nitrogen, which can be hydrogen bond donors. As a result, 
hydrogen bonding interactions might be present between PCL and ampicillin inside 
the nanofibers. The molecular structures of PCL and ampicillin are shown in Figure 
4.15.  
 
 
 
Figure 4.15. Molecular structures of (a) ampicillin and (b) PCL 
 
The ATR-FTIR spectra of the ampicillin, PCL and nanofibers produced from them 
are shown in Fig. 4.16.  
 
For PCL, several peaks were observed. A strong peak at 1724 shows the C=O stretch 
which belongs to esters. It can be seen from the spectrum of all samples which 
include PCL. Such a peak is not present in ampicillin. A medium peak at 2944 shows 
the C–H stretch which is present in alkanes. A strong peak at 1174 shows the C–O 
(a) (b) 
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stretch of esters. A medium peak at 1470 refers to the C–H bends which belongs to 
the alkanes. A medium peak between 1365 indicates the C–H rock of alkanes. 
 
 
Figure. 4.16. ATR-FTIR spectra of Ampicillin, PCL and electrospun membranes 
 
There are several peaks for ampicillin. The peaks of ampicillin within the range of 
650 and 1500 were too close to each other and overlapping was present. Medium 
peak at 1585 refers to the N–H bend of 1˚ amines. That peak can also be observed on 
the FTIR spectra of the membranes (indicated by red circle). This verifies the 
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presence of ampicillin inside those membranes. Medium peak at 1454 shows the C–
C stretch of (in–ring) aromatics. The peak at 1126 indicates C–O stretch. For all the 
electrospun membranes the peaks generally belonged to PCL because the amount of 
PCL is much more than ampicillin in these compounds. 
 
4.5. In vitro drug release profiles 
 
Drug release profile was examined with the help of UV spectroscopy by measuring 
the ampicillin concentration inside the release media between certain time intervals. 
In order to determine the amount of ampicillin in release media, firstly a calibration 
curve showing the connection between UV absorbance and concentration in PBS was 
drawn by using known concentrations of ampicillin. The calibration curve used for 
this purpose is shown on Materials & Methods section. The formula derived from the 
calibration curve is:  
 
𝐶 = 9.033 × 𝐴 
 
where C is the ampicillin concentration and A is the absorbance of the solution at 
325 nm. 
 
It is known from the literature that, in the release environment (PBS), PCL is not 
swellable and it has a very slow degradation rate [72, 73]. These two features 
eliminate the swelling controlled and chemically controlled drug release 
mechanisms. As a result, the controlled release mechanism from PCL membranes is 
presumed to be diffusion-controlled. Two equations were chosen for describing the 
diffusion controlled drug release kinetics from sample membranes. Those two 
equations are Peppas equation (Equation 2.6) and zero-order kinetics equation 
(Equation 2.3). 
(4.1) 
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 Figure 4.17. In vitro drug release profiles of Core/Shell 1 (CS1), Core/Shell 2 (CS2) 
and Core (CR) membranes (full range) 
 
 
Figure 4.18. In vitro drug release profiles of Core/Shell 1 (CS1), Core/Shell 2 (CS2) 
and Core (CR) membranes in first 4 hours 
 
The drug release profiles of CS1, CS2 and CR in the first 4 hours are shown in 
Figure 4.18. The sample named CR produced by single electrospinning of the core 
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released 85 ± 6 % of the ampicillin within first 4 hours. This indicated the burst 
release. The coaxially electrospun sample CS1 released 16 ± 2 % of the drug and the 
one named CS2 released 7 ± 2 % percent of the drug. Both of them have reduced the 
burst release effect. Moreover, sample CS2, which has greater shell flow rate showed 
less burst release. This indicates the thickening of shell part of those nanofibers. The 
burst release observed on sample CR can be due to: 
 
a) The lower compatibility of ampicillin inside PCL fibers 
b) The accumulation of ampicillin on fiber surface 
c) Absence of a shell layer, which would delay the release 
 
The general drug release profiles of the samples are shown in Figure 4.17. Sample 
CR released 98 ± 2 % of ampicillin in 24 hours. After the burst release, the lag 
release period is observed. This release profile can be analyzed by the Peppas 
equation.  
 
The regressed equation (into Peppas equation) for CR between 0 and 24 hours is as 
follows:  
 
QCR = 74,885 x t
0,0875
 (R² = 0,9848) 
 
The k value (74,885) is determined by the structure/geometry of the matrix and the n 
value (0,0875) represents the release mechanism. The release mechanism can be 
described as Fickian diffusion when the n value is equal to or below 0,45 [74]. The n 
value in this equation is much smaller than 0,45 which can be due to the rapid burst 
release. If the burst release was slower, the n value would be closer to 0,45. 
Moreover, in a study where release kinetics of metronidazole benzoate from PCL 
nanofibers was investigated, n values between 0.31-0.44 were found for different 
drug concentrations. In the same study, it was observed that n value decreased with 
increase in drug concentration [75]. As a result, another reason for low n value found 
in this study can be high concentration of ampicillin inside PCL membranes. From 
(4.2) 
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the regression of the formula it can be understood that the drug release from CR 
membrane was through Fickian diffusion.  
 
Samples CS1 released 96 ± 4 % and CS2 released 95 ± 4 % of the drug within 72 
hours. After that, they both entered the lag period. The drug release kinetics of those 
samples is closer to the zero-order kinetics equation. Peppas equation cannot be 
applied to those samples due to the non-homogenous distribution of the drug inside 
the matrix (one of the assumptions of Peppas equation). It was eliminated by the 
shell layer with blank PCL (without drug). 
 
The regressed equations (into zero order kinetics equation) for CS1 and CS2 between 
0 and 72 hours are as follows:  
 
QCS1 = 6,9471 + 1,2018t (R² = 0,9796) 
 
QCS2 = 0,1341 + 1,2279t (R² = 0,9789) 
 
Q0 (6,9471 for CS1 and 0,1341 for CS2) refers to the initial amount of drug inside the 
medium. It should be equal to zero as the release medium has no drug at t=0. As the 
Q0 value for CS2 membranes is much closer to zero, it is more suitable for zero order 
kinetics equation. On the other hand, the zero order release constants (1,2018 for 
CS1 and 1,2279 for CS2) were close to each other with a small difference due to the 
different shell thicknesses of the membranes.  In other studies, where modified 
coaxial electrospinning was used, the release profile changed with polymer type. 
When zein was used as the carrier polymer, a release profile closer to zero order 
release kinetics was achieved in the first 16 hours [19]. Another study found that 
cellulose acetate was used, a similar release profile was obtained in the first 96 hours 
[20]. In this study, as the polymer type, the drug, polymer concentration and flow 
rates are different; a zero order release profile was obtained for the first 72 hours. 
The release profile can be further changed by changing those parameters for 
obtaining a profile with less burst release. In another study, a longer release period of 
a drug (dipyridamole) was achieved by using PCL as the shell layer. However, the 
(4.3) 
(4.4) 
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drug release profile was not suitable for zero-order drug release kinetics equation. 
Moreover, the drug used in that study was a platelet aggregation inhibitor which can 
be used for dilating the blood vessels in people with several diseases [76]. The 
desired drug release duration of that process is higher than the one where antibiotics 
are used. Antibiotics are generally used in wound healing applications where a 
release duration of even several hours might be sufficient [77].   
 
Moreover, CS2 with higher shell flow rate showed a slower drug release profile than 
CS1. This shows that the main feature determining the release profile is the shell 
thickness. The shell thickness can be adjusted by shell flow rate or the polymer 
concentration of the shell fluid. In section 4.2 it was observed that the shell flow rate 
can only be between a certain range (0.5-0.6 ml/h) for the formation of stable Taylor 
cone. Because of this fact, by increasing or decreasing the polymer concentration, the 
drug release can be easily controlled instead of changing the shell flow rate in future 
studies.  
 
Finally, the encapsulation efficiencies of three sample membranes were calculated. It 
was found that the encapsulation efficiencies of CR, CS1 and CS2 are 83.6 ± 1.01, 
93.5 ± 0.54 and 94.7 ± 1.0, respectively. From the results of the ANOVA test 
followed by the Tukey’s HSD test, it was found that there is no significant difference 
between the encapsulation efficiencies of CS1 and CS2 (p > 0.05). However, CR 
membrane was significantly different from both CS1 and CS2. The reason of the 
core shell membranes having higher encapsulation efficiency than the CR membrane 
is speculated to be due the shell layer. Shell layer of the core shell membranes might 
have prevented the loss of drug during the membrane production process.  
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5. CONCLUSION AND FUTURE STUDIES 
 
In this study, ampicillin-loaded PCL nanofibers coated with blank PCL was 
successfully produced via modified coaxial electrospinning process using dilute and 
partially electrospinnable PCL solution as the shell. Using 4% (w:v) PCL solution as 
the shell fluid resulted with less plugging on the needle tip, smaller fiber diameters 
and sustained release of the drug. 
 
From the SEM images the average fiber diameters were measured as 464 ± 214 and 
567 ± 180 nm for shell to core flow rate ratios of 1 (CS1) and 1.2 (CS2), 
respectively. It was found that average fiber diameter of CR (702 ± 166 nm) was 
greater than both CS1 and CS2. The reason for the difference in average fiber 
diameters was thought to be due to the amount of solid solutes exported from the 
nozzle. The optical images of two core-shell nanofibers from each sample proved 
that the core was successfully covered with the shell layer. It was demonstrated from 
the ATR-FTIR spectra that PCL might have some compatibility with ampicillin 
because of hydrogen bonding. Moreover, presence of ampicillin in the synthesized 
membranes was verified by the peak which belongs to N–H bend of 1˚ amines.  
 
Drug release studies showed that nanofibers coated with 4% (w:v) PCL showed a 
decrease in burst release and a profile closer to linear release was achieved in the first 
72 hours due to the shell layer acting as a diffusion-retarding barrier. On the other 
hand, burst release was observed for single electrospinning of the core solution. 
Finally, encapsulation efficiency results showed that nanofibers synthesized by 
coaxial electrospinning have significantly higher encapsulation efficiency than the 
membranes synthesized by single electrospinning. 
 
In this study, the application area of modified coaxial electrospinning process was 
extended by using it for the controlled release of a hydrophilic drug. In addition to 
providing sustained release, the process also resulted with smaller fiber diameters 
and less plugging compared to single electrospinning. In the future, Transmission 
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Electron Microscopy images of the core-shell structured nanofibers will be taken. 
Moreover, the effect of membrane thickness on drug release profile will be 
examined. 
 
This approach will be used by our research group for further applications which are: 
 
 Additional controlling of the drug release profile by changing the 
concentration and flow rate of the shell fluid. 
 Controlled release of biological agents other than hydrophobic or hydrophilic 
drugs. Some examples for those agents are peptides, proteins, growth factors and 
plasmid DNA. 
 Production of finer fibers by using the solvent mixture alone as the shell fluid 
in order to increase the surface area for biosensor applications. 
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A. Derivation of Fick’s First and Second Laws of Diffusion 
 
Firstly, a collection of particles performing a random walk is considered. The length 
scale of the one dimensional walk is ∆x and the time scale is ∆t. Finally, N(x,t) is the 
number of particles which is present at position x at time t. At point x, half of the 
particles would move to the right and at point x + ∆x, half of the particles would 
move to the left [78]. The net movement to the right can be shown as:  
 
−
1
2
 ×  (𝑁(𝑥 + ∆𝑥, 𝑡) − 𝑁(𝑥 − 𝑡)) 
 
J (flux) means the net movement of particles through a surface area of A within the 
time interval ∆t. It can be written as: 
 
𝐽 = −
1
2
 ×  ( 𝑁(𝑥 + ∆𝑥, 𝑡) ÷ 𝐴∆𝑡 − 𝑁(𝑥 − 𝑡) ÷ 𝐴∆𝑡) 
 
If up and down sides of the equation is multiplied by (∆x)2: 
 
𝐽 = −
∆𝑥2
2∆𝑡
( 𝑁(𝑥 + ∆𝑥, 𝑡) ÷ 𝐴∆𝑥2 − 𝑁(𝑥 − 𝑡) ÷ 𝐴∆𝑥2) 
 
Concentration (C) is equal to number of particles per unit volume which is N/(A∆x) 
and diffusion constant is expressed as (∆x)2/(2∆t). By using those definitions, the 
equation can be simplified into: 
 
𝐽 = −𝐷( 𝐶(𝑥 + ∆𝑥, 𝑡) ÷ ∆𝑥 − 𝐶(𝑥 − 𝑡) ÷ ∆𝑥) 
 
By taking the limit of the right side: 
 
𝐽 = −𝐷
𝑑𝐶
𝑑𝑥
 
 
(A.1) 
(A.4) 
(A.3) 
(A.2) 
(A.5) 
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Where, D is the diffusion constant, C refers to the concentration and x is the position. 
This equation gives Fick’s first law of diffusion from which Fick’s second law can 
be derived. By considering mass conservation:  
 
𝜕𝐶
𝜕𝑡
+
𝜕
𝜕𝑥
 𝐽 =  0 
 
By using Fick’s first law:  
 
𝜕𝐶
𝜕𝑡
−
𝜕
𝜕𝑥
 (𝐷
𝑑𝐶
𝑑𝑥
) =  0 
 
And finally Fick’s second law of diffusion is described as: 
 
𝜕𝐶
𝜕𝑡
= 𝐷
𝜕2𝐶
𝜕𝑥2
  
 
Where, D refers to the diffusion constant, t is the time, C is the concentration and x is 
the position. 
 
B. Derivation of Zero and First Order Release Equations 
 
The differential equation used for describing zero-order drug release kinetics is: 
 
𝑑𝐶
𝑑𝑡
=  𝑘 
 
Where, t is time, C is the drug concentration and k is the zero order kinetics constant. 
After rearrangement:  
 
𝑑𝐶 = 𝑘𝑑𝑡 
 
After integration: 
 
(A.6) 
(A.8) 
(A.7) 
(B.1) 
(B.2) 
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𝐶𝑡 − 𝐶0 = 𝑘𝑡 
 
𝐶𝑡 = 𝐶0 +  𝑘𝑡  
 
Where, C0 is the initial drug concentration, Ct is the drug concentration at a certain 
time (t) and k is the zero order kinetics constant.  
 
The differential equation used for describing first-order drug release kinetics is: 
 
𝑑𝐶
𝑑𝑡
= 𝑘𝐶 
 
Where, t is time, C is the drug concentration in release medium and k is the first 
order kinetics constant. After rearrangement: 
 
𝑑𝐶
𝐶
= 𝑘𝑑𝑡 
 
After integration: 
 
ln
𝐶𝑡
𝐶𝑜
= 𝑘𝑡 
 
𝐶𝑡
𝐶𝑜
= 𝑒 𝑘𝑡 
 
In decimal logarithms: 
 
log 𝐶𝑡 = log 𝐶𝑜 + 
𝑘𝑡
2.303
 
 
Where, C0 is the initial drug concentration, Ct is the drug concentration at a certain 
time (t) and k is the first order kinetics constant. 
 
(B.3) 
(B.7) 
(B.4) 
(B.6) 
(B.5) 
(B.8) 
(B.9) 
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C. Derivation of Higuchi equation and Peppas equation 
 
 
 
 
Figure A.1. Schematic illustration of the drug concentration - distance profile of the 
matrix exposed at time t and t + dt. 
 
In Figure A.1, the grey area represents the amount of drug released from the matrix 
per area. It can be illustrated by the equation [79]: 
 
𝑀𝑡
𝐴
= (𝐶𝑖𝑛 −  
𝐶𝑠
2
)  𝑥 ℎ 
 
Where, Mt is the drug released from the matrix at time t, Cin refers to the initial drug 
concentration, Cs represents the drug solubility, and h is the distance of the front. The 
cumulative amount of drug released per unit surface area dM/A in the time interval dt 
can be shown as: 
 
𝑑𝑀
𝐴
= 𝐶𝑖𝑛 𝑥 𝑑ℎ − 
𝐶𝑠
2
 𝑥 𝑑ℎ 
 
If Fick's 1st law of diffusion is used and a saturated drug solution is considered: 
 
(C.1) 
(C.2) 
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𝑑𝑀
𝑑𝑡
= 𝐴 𝑥 𝐷 
𝐶𝑠
ℎ
 
 
Where, D is the diffusion coefficient and h is the distance from the surface (at perfect 
sink conditions). By combining equation (C.2) and (C.3): 
 
ℎ =  2√
𝐷𝑡𝐶𝑠
2𝐶𝑖𝑛−𝐶𝑠
 
 
By substituting equation (C.4) into equation (C.1): 
 
𝑀𝑡
𝐴
=  √(2𝐶𝑖𝑛 − 𝐶𝑠)𝐷𝑡𝐶𝑠 
 
If Cin is much greater than Cs the equation can be simplified to: 
 
𝑀𝑡
𝐴
=  √(2𝐶𝑖𝑛𝐷𝑡𝐶𝑠) 
 
If A, Cin, D and Cs are taken as constant, the final equation found is: 
 
𝑀𝑡 =  𝑘𝐻√𝑡 = 𝑘𝐻𝑡
1/2 
 
However, Higuchi equation is used to describe the release from a carrier matrix with 
thin planar geometry and it was suitable for Fickian diffusion mechanism [79]. It was 
not applicable for cylinders and spheres. Another equation was proposed by Peppas 
for modelling the drug release from different carrier matrixes and which is also 
acceptable for non-Fickian diffusion. The more generic equation proposed by Peppas 
is: 
 
𝑀𝑡
𝑀∞
= 𝑘𝑡𝑛 
 
(C.3) 
(C.6) 
(C.5) 
(C.4) 
(C.7) 
(C.8) 
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The n value in this equation was used for characterizing different release 
mechanisms. For cylindrical shaped matrix, n=0.45 means Fickian diffusion and n 
values between 0.45 and 0.89 refers to non-Fickian diffusion mechanism. The k 
value is the rate constant which depends on the geometrical shape of the matrix [29].  
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